ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 682

Correlation Between the Lupus Foundation of America – Rapid Evaluation of Activity in Lupus (LFA-REAL) Patient Reported Outcome (PRO) and Health-Related Quality of Life (HRQoL) and Other PROs in a Primarily Mestizo Population

Manuel Ugarte-Gil1, Rocío-V. Gamboa-Cárdenas 2, Victor Pimentel-Quiroz 3, Cristina Reátegui-Sokolova 4, Paola Zeña-Huancas 2, Mariela Medina 2, Claudia Elera-Fitzcarrald 1, Luciana Gil 2, Samira García 4, Francisco Zevallos 4, Cesar Pastor-Asurza 4, Zoila Rodríguez-Bellido 2, Anca Askanase 5, Joan Merrill 6, Graciela Alarcón 7 and Risto Perich-Campos 2, 1Universidad Científica del Sur, Lima, Peru, 2Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Lima, Peru, 3Hospital Nacional Guillermo Almenara Irigoyen - EsSalud, Lima, Lima, Peru, 4Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, 5Columbia University, New York, 6Oklahoma Medical Research Foundation, Oklahoma City, 7University of Alabama at Birmingham, Birmingham

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Disease Activity and quality of life, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: SLE – Clinical Poster I: Epidemiology & Pathogenesis

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Disease activity in systemic lupus erythematosus (SLE) is understood differently by patients and physicians; furthermore, there are no reliable measures for patients to assess their levels of disease activity. The LFA-REAL PRO has been proposed for addressing this void, and it is expected to correlate with HRQoL and with other PROs. The aim of this study was to determine the correlations between LFA-REAL PRO and HRQoL, fatigue and work disability.

Methods: A cross-sectional analyses of patients from a single-center cohort was performed. The disease activity measure included was the LFA-REAL PRO (0-1200); PROs included were LupusQoL (with its eight domains), SF-36 (with its eight domains and two main subcomponents), FACIT (as a measure of fatigue) and WPAI (as a measure of work productivity impairment). For the LFA-REAL PRO and WPAI, the higher the scores, the worse the disease activity and the more impaired the patient is;  for the SF-36, LupusQoL and FACIT is the opposite. The correlation between these indices was evaluated with Pearson correlations.

Results: One-hundred and sixty-nine patients with SLE, with a mean age of 45.8 (SD: 14.2), 156 (92.3%) were female. The mean (SD) the LFA-REAL PRO was 239.6 (187.7), the Physical Component Summary SF-36 was 53.7 (22.1) and the Mental Component Summary SF-36 was 54.6 (21.0). The mean value of the components of the LupusQoL ranged between 41.0 and 69.4. The FACIT was 33.2 (10.5), the percentage of overall work productivity impairment was 30.8 (28.1) and of activity impairment was 36.1 (29.9). LFA-REAL PRO correlated with all domains of LupusQoL, SF-36, FACIT and WPAI, with the exception of absenteeism.

Conclusion: The LFA-REAL PRO correlates with several measures of HRQoL and other outcomes relevant to lupus patients like fatigue and work disability, suggesting that this index could be useful in monitoring them.


Table 1 pro


Disclosure: M. Ugarte-Gil, None; R. Gamboa-Cárdenas, None; V. Pimentel-Quiroz, None; C. Reátegui-Sokolova, None; P. Zeña-Huancas, None; M. Medina, None; C. Elera-Fitzcarrald, None; L. Gil, None; S. García, None; F. Zevallos, None; C. Pastor-Asurza, None; Z. Rodríguez-Bellido, None; A. Askanase, Xencor, 2; J. Merrill, Xencor, 2; G. Alarcón, None; R. Perich-Campos, None.

To cite this abstract in AMA style:

Ugarte-Gil M, Gamboa-Cárdenas R, Pimentel-Quiroz V, Reátegui-Sokolova C, Zeña-Huancas P, Medina M, Elera-Fitzcarrald C, Gil L, García S, Zevallos F, Pastor-Asurza C, Rodríguez-Bellido Z, Askanase A, Merrill J, Alarcón G, Perich-Campos R. Correlation Between the Lupus Foundation of America – Rapid Evaluation of Activity in Lupus (LFA-REAL) Patient Reported Outcome (PRO) and Health-Related Quality of Life (HRQoL) and Other PROs in a Primarily Mestizo Population [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/correlation-between-the-lupus-foundation-of-america-rapid-evaluation-of-activity-in-lupus-lfa-real-patient-reported-outcome-pro-and-health-related-quality-of-life-hrqol-and-other-pros-in-a-pri/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation-between-the-lupus-foundation-of-america-rapid-evaluation-of-activity-in-lupus-lfa-real-patient-reported-outcome-pro-and-health-related-quality-of-life-hrqol-and-other-pros-in-a-pri/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology